Archives
-
Palonosetron: Pharmacology, PK, and Clinical Evidence
2026-09-17
The 2010 reference review presents palonosetron hydrochloride as a highly selective 5-HT3 receptor antagonist whose unusually strong receptor affinity and approximately 40-hour elimination half-life help explain sustained control of chemotherapy-related emesis. Its integrated binding, animal pharmacology, pharmacokinetic, and randomized clinical evidence supports noninferior acute protection and superior delayed protection compared with granisetron in the studied setting.
-
Cannabis Terpenes Activate A2A Receptors in Neuropathic Pain
2026-09-17
Schwarz and colleagues show that five Cannabis sativa terpenes reduce nociceptive hypersensitivity in mouse models of chemotherapy-induced peripheral neuropathy and inflammatory pain. The study combines behavioral pharmacology, spinal receptor knockdown, cAMP and binding assays, and computational modeling to identify adenosine A2A receptor activation as a key mechanism, while also finding no conditioned place preference.
-
D-N-Acetylgalactosamine: Protocol and QC Guide
2026-09-16
D-N-Acetylgalactosamine (SKU B7904) provides a defined, high-purity reagent for aqueous workflows involving glycoprotein composition, brain heteropolysaccharides analysis, and related glycosylation studies. It is suitable for water or compatible DMSO preparations, but not for ethanol-based protocols or long-term storage of prepared solutions.
-
Preserving Phosphosignals in Precision Neuro-Oncology
2026-09-16
Translational oncology depends on measurements that survive the transition from living tissue to experimental readout. This thought-leadership article explains how Phosphatase Inhibitor Cocktail 1 (100X in DMSO) supports protein phosphorylation preservation, strengthens phosphoproteomic analysis, and helps researchers interpret metabolic and epigenetic findings in H3K27M-mutant diffuse midline glioma without overstating what the current evidence proves.
-
Atorvastatin Beyond Lipids: A Translational Playbook
2026-09-15
Atorvastatin is more than a cholesterol biosynthesis inhibitor. This thought-leadership article connects HMG-CoA reductase biology with vascular signaling, endoplasmic reticulum stress, and emerging ferroptosis research in hepatocellular carcinoma, while outlining practical validation and translational decision points.
-
LG 101506: RXR-to-PD-L1 Assay Design
2026-09-15
LG 101506 is an RXR modulator for dissecting nuclear receptor signaling without confusing receptor pharmacology with PD-L1 checkpoint biology. This article presents a causal, multi-layer assay strategy grounded in RBMS1 research and designed for rigorous RXR signaling pathway research.
-
Cholesterol in LNP Workflows: Practical Guide
2026-09-14
Cholesterol is more than a structural excipient: it is a controllable variable for LNP rigidity, membrane behavior, and molecular organization. This guide connects practical preparation, membrane fluidity assay design, cryogenic imaging, and troubleshooting to the latest label-free depth-profiling workflow.
-
Acetoacetic Acid Sodium Salt Workflow Guide
2026-09-14
Build more reproducible ketone-body assays with a water-soluble, 98% pure acetoacetate source designed for calibration, metabolic perturbation, and pathway-focused experiments. This guide combines practical handling of sodium 3-oxobutanoate with isotope-aware quality controls inspired by a deuterium-labeling study.
-
Thymoquinone Workflows for Cardiotoxicity Research
2026-09-13
Build mechanism-resolved doxorubicin cardiotoxicity assays with Thymoquinone, from solvent handling through ferroptosis, oxidative-stress, and cardiac-function readouts. The workflow separates study-matched mouse dosing from practical cell-culture optimization while highlighting controls that distinguish antioxidant protection from nonspecific cytotoxicity.
-
5-Aminolevulinic Acid HCl in Heme Research
2026-09-12
5-Aminolevulinic acid HCl is more than an intermediate in heme biosynthesis: it is a useful probe for separating metabolic flux, bacterial immune evasion, and assay readouts. This article translates recent Salmonella findings into practical experimental decisions while defining the reagent’s relevance to cancer research.
-
Dynasore: From Endocytosis Tool to Translation Strategy
2026-09-11
Dynasore is more than a pathway inhibitor: it is a reversible perturbation tool for testing whether dynamin-dependent membrane fission drives uptake, trafficking, infection, neuronal recycling, or disease-relevant signaling. This article translates mechanistic evidence into practical experimental and translational strategy.
-
Cy5-UTP for Structure-Resolved RNA Probes
2026-09-11
Cy5-UTP enables bright, direct RNA detection while exposing an often-overlooked experimental variable: fluorescent labeling can influence RNA structure and RNA–protein binding. This guide translates XIST–SPEN research into a rigorous workflow for in vitro transcription RNA labeling, FISH, and multiplex assay design.
-
Beyond Viability: Resazurin in Sclerosteosis Research
2026-09-10
A translational framework for using resazurin-based viability measurements to strengthen PORCN inhibition studies in SOST-deficient high-bone-mass disease.
-
CX-5461 Triggers Mitotic Catastrophe in Cervical Cancer
2026-09-10
A June 2026 study reports that the RNA polymerase I inhibitor CX-5461 suppresses cervical cancer cell growth by coupling DNA damage to aberrant mitotic entry and mitotic catastrophe. The work also provides a mechanistic rationale for combining Pol I inhibition with cisplatin, particularly in models relevant to treatment resistance.
-
Bradykinin B2 Receptors and Ileal Peristalsis
2026-09-09
Chan and Rudd showed that bradykinin inhibits the peristaltic reflex in guinea pig ileum through pharmacologically identifiable B2 receptors, rather than B1 receptors. Their agonist–antagonist design links receptor subtype selectivity to a functional motility endpoint and provides a useful framework for interpreting peptide signaling in gastrointestinal research.